185 related articles for article (PubMed ID: 24481483)
1. Effectiveness of intraocular pressure-lowering medication determined by washout.
Jampel HD; Chon BH; Stamper R; Packer M; Han Y; Nguyen QH; Ianchulev T
JAMA Ophthalmol; 2014 Apr; 132(4):390-5. PubMed ID: 24481483
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors as fourth drug in primary glaucomas: Is it worth it?
Juncal VR; Abdo Jorge F; Paranhos A; Santos Prata T
Can J Ophthalmol; 2015 Aug; 50(4):297-301. PubMed ID: 26257224
[TBL] [Abstract][Full Text] [Related]
3. Effect of laser trabeculoplasty on nocturnal intraocular pressure in medically treated glaucoma patients.
Lee AC; Mosaed S; Weinreb RN; Kripke DF; Liu JH
Ophthalmology; 2007 Apr; 114(4):666-70. PubMed ID: 17188360
[TBL] [Abstract][Full Text] [Related]
4. Intraocular Pressure Following Prerandomization Glaucoma Medication Washout in the HORIZON and COMPASS Trials.
Johnson TV; Jampel HD
Am J Ophthalmol; 2020 Aug; 216():110-120. PubMed ID: 32289292
[TBL] [Abstract][Full Text] [Related]
5. Association of ocular hypotensive medication types with dynamic contour tonometry and Goldmann applanation tonometry measurements in a glaucoma and ocular hypertensive population.
Tzamalis A; Kynigopoulos M; Chalvatzis N; Dimitrakos S; Schlote T
J Ocul Pharmacol Ther; 2013 Feb; 29(1):41-7. PubMed ID: 23066787
[TBL] [Abstract][Full Text] [Related]
6. Is addition of a third or fourth antiglaucoma medication effective?
Neelakantan A; Vaishnav HD; Iyer SA; Sherwood MB
J Glaucoma; 2004 Apr; 13(2):130-6. PubMed ID: 15097258
[TBL] [Abstract][Full Text] [Related]
7. Effects of several anti-glaucoma medications on the circadian intraocular pressure fluctuations in patients with primary open-angle glaucoma.
Tanaka S; Watanabe M; Inatomi S; Umeda K; Yoshida K; Ohguro I; Ohguro H
J Ocul Pharmacol Ther; 2014 Feb; 30(1):12-20. PubMed ID: 24286181
[TBL] [Abstract][Full Text] [Related]
8. Single vs multiple intraocular pressure measurements in glaucoma surgical trials.
Zhang ML; Chon BH; Wang J; Smits G; Lin SC; Ianchulev T; Jampel HD
JAMA Ophthalmol; 2014 Aug; 132(8):956-62. PubMed ID: 24831204
[TBL] [Abstract][Full Text] [Related]
9. Validity of the Monocular Trial of Intraocular Pressure-Lowering at Different Time Points in Patients Starting Topical Glaucoma Medication.
King AJ; Rotchford AP
JAMA Ophthalmol; 2016 Jul; 134(7):742-7. PubMed ID: 27148831
[TBL] [Abstract][Full Text] [Related]
10. Effect of 6-week washout period on intraocular pressure following chronic prostaglandin analogue treatment: a randomized controlled trial.
Lim CW; Diaconita V; Liu E; Ault N; Lizotte D; Nguyen M; Hutnik CML
Can J Ophthalmol; 2020 Apr; 55(2):143-151. PubMed ID: 31712013
[TBL] [Abstract][Full Text] [Related]
11. Medical therapy for glaucoma: what to add after a prostaglandin analogs?
Tanna AP; Lin AB
Curr Opin Ophthalmol; 2015 Mar; 26(2):116-20. PubMed ID: 25594765
[TBL] [Abstract][Full Text] [Related]
12. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
Katz G; Dubiner H; Samples J; Vold S; Sall K
JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
[TBL] [Abstract][Full Text] [Related]
13. 24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma.
Feldman RM; Stewart RH; Stewart WC; Jia G; Smugar SS; Galet VA
Curr Med Res Opin; 2008 Aug; 24(8):2403-12. PubMed ID: 18627642
[TBL] [Abstract][Full Text] [Related]
14. Relation between office intraocular pressure and 24-hour intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops.
Nakakura S; Nomura Y; Ataka S; Shiraki K
J Glaucoma; 2007 Mar; 16(2):201-4. PubMed ID: 17473730
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.
Feldman RM; Tanna AP; Gross RL; Chuang AZ; Baker L; Reynolds A; Prager TC;
Ophthalmology; 2007 Jul; 114(7):1248-54. PubMed ID: 17509688
[TBL] [Abstract][Full Text] [Related]
16. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
Brandt JD; Beiser JA; Gordon MO; Kass MA;
Am J Ophthalmol; 2004 Nov; 138(5):717-22. PubMed ID: 15531304
[TBL] [Abstract][Full Text] [Related]
17. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.
Liu JH; Medeiros FA; Slight JR; Weinreb RN
Ophthalmology; 2009 Mar; 116(3):449-54. PubMed ID: 19157559
[TBL] [Abstract][Full Text] [Related]
18. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
Maruyama K; Shirato S
J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.
Eren MH; Gungel H; Altan C; Pasaoglu IB; Sabanci S
J Ocul Pharmacol Ther; 2012 Aug; 28(4):381-6. PubMed ID: 22320418
[TBL] [Abstract][Full Text] [Related]
20. Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.
Ormrod D; McClellan K
Drugs Aging; 2000 Dec; 17(6):477-96. PubMed ID: 11200308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
